All In Biotech

Drug Trial Radar · NCT00563485

Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up

Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily in the Successful Rate of Trial Without Catheter in Acute Urinary Retention With Long Term Follow up

Last checked: Nov 20, 2026Latest source record: Jun 16, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

120

Planned (sponsor's estimate)

Start

Oct 2005

Primary completion

Not stated

Study completion Nov 2006

Sponsor

Lead sponsor
Hospital Authority, Hong KongGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
Nov 26, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
Male only, from 50 years

Summary

As written by the sponsor on the registry.

The purpose of the study is to compare two alpha blockers, terazosin and doxazosin GITS, in achieving a successful TWOC after AUR due to BPH, among Chinese males in Hong Kong, and in delaying or avoiding a TURP.

Conditions

  • Prostatic Hyperplasia
  • Urinary Retention

Interventions

  • Doxazosin GITS (Cardura XL)Drug

  • Terazosin (Hytrin)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Successful rate of Trial Without Catheter (TWOC) at phase 1Time frame: At discharge after TWOC (at the end phase one)
  2. Late failure of TWOC of, which is defined as recurrent of AUR or the need of invasive therapy among those who are successful in TWOC in phase 1Time frame: From the end of phase one to eight months after successful TWOC (the end of phase 2)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Prince of Wales Hospital

    Hong Kong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.